Comhair, Suzy A. A.
Bochenek, Grazyna
Baicker-McKee, Sara
Wang, Zeneng
Stachura, Tomasz
Sanak, Marek
Hammel, Jeffrey P.
Hazen, Stanley L.
Erzurum, Serpil C.
Nizankowska-Mogilnicka, Ewa
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (HL081064, HL103453,)
Uniwersytet JagielloĊski Collegium Medicum (K/ZDS/002794)
Center of Innovation Award by AB SCIEX
Article History
Received: 25 April 2018
Accepted: 9 October 2018
First Online: 30 October 2018
Ethics approval and consent to participate
: The Ethics Committee at Jagiellonian University approved the study, which was carried out according to the declaration of Helsinki. All participants provided written informed consent.
: Not applicable
: SLH is named as co-inventor on pending and issued patents held by the Cleveland Clinic relating to cardiovascular diagnostics and asthmatic therapeutics, and has the right to receive royalty payment for inventions or discoveries both related tocardiovascular and asthmatic diagnostics or therapeutics from the Cleveland Clinic, Quest Diagnostics and Proctor & Gamble. SLH also reports having been paid as a Consultant from Proctor & Gamble, and having received research funds from Proctor & Gamble and Roche.DD.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.